Making sense of chaos in the GLP-1 space.
A study of over 333,000 veterans with diabetes linked stopping GLP-1s to fading heart benefit. See what it found and what it can't prove.
By Lauren Pescarus
Retatrutide isn't approved anywhere, yet it's sold online. See what JAMA found in black market vials and how to spot a safe pharmacy.
A new survey linked GLP-1s to nail lifting. See the real numbers, why experts say it's too early to worry, and what to do if your nails change.
A new Lancet review of 43,000 women found no clear link to birth defects. See who it studied, the one number to watch, and what the labels say.
Big telehealth brands plan to sell peptides. Learn which ones have a legal path, what the LegitScript seal checks, and the red flags.
Some GLP-1 users say they feel flat. Three published cases, what the large trials found, and what to do if it happens to you.
A reviewer walks through Remedy Meds: $279 first month, a video visit revealed after payment, and a 365-day guarantee he was never eligible for.
Remedy MedsFDA's September 2026 warning letter has two separate sets of findings. See which one affects patients and which is a legal dispute.
Even at no cost, 10% of new prescriptions go unfilled. See where reducing what patients owe actually changes behavior, and where it does not.
The GLP-1 Bridge now runs through 2027. Six things to check before December 7, including plan type and the fill that ends eligibility.
Inside a Strive Pharmacy compounded tirzepatide box: a cooler box, thawed gel packs, the 10/5/500 label transcribed, and how to reach a pharmacist.
MEDViOne patient shares real MEDVi experience: $199 at checkout, $299 on renewal, upsells that drop when you say no, and a $100 cancel discount.
MEDViEmployers are dropping GLP-1 coverage. See how to check any plan's drug list before open enrollment closes, and what the conditions mean.
Lawsuits put GLP-1 vision loss back in the news. See the absolute risk, what regulators concluded in 2025, and why the US label differs.
A $95 peptide vial had a brand, a shop and a lab report. See which signals are easy to fake and what a licensed pharmacy is really held to.
